Rayborn Michong K, Turner John L, Park Sun G
College of Nursing, University of Southern Mississippi at Hattiesburg, Mississippi, USA.
Pinebelt Anesthesia Associates PLLC, Hattiesburg, Mississippi, USA.
J Perioper Pract. 2017 Jun;27(6):129-134. doi: 10.1177/175045891702700603.
The objective of this study was to determine whether routine preoperative type and screen blood testing is cost effective and medically warranted for benign diagnosis in healthy patients undergoing robotic hysterectomy. The study was designed as a cross sectional retrospective descriptive study. Four hundred and twenty two medical records of American Society of Anesthesiologists (ASA) Classifications I and II patients undergoing robotically-assisted laparoscopic hysterectomy between 1 June 2011 and 31 May 2014 at a 211 bed regional medical center were analysed. The results from this study paralleled the findings of other published research. Preoperative type and screen testing was performed on 249 (59%) of the patients in the study. Ten patients (2.4% of the group) converted to open laparotomy. Mean estimated blood loss was 59.59ml. No perioperative transfusions were required. The results indicate that preoperative type and screen testing is not warranted for patients meeting the inclusion criteria.
本研究的目的是确定对于接受机器人子宫切除术的健康患者，术前常规血型和筛查血液检测在成本效益方面是否合理以及在医学上是否必要用于良性诊断。该研究设计为横断面回顾性描述性研究。分析了2011年6月1日至2014年5月31日期间在一家拥有211张床位的地区医疗中心接受机器人辅助腹腔镜子宫切除术的美国麻醉医师协会（ASA）I级和II级患者的422份病历。本研究结果与其他已发表研究的结果相似。研究中的249名（59%）患者进行了术前血型和筛查检测。10名患者（占该组的2.4%）转为开腹手术。平均估计失血量为59.59毫升。围手术期无需输血。结果表明，对于符合纳入标准的患者，术前血型和筛查检测并无必要。
